CanadaBis CapitalTSXV:CANB Days Payable is 384.91 as of Oct. 2025, which is 121% above its 10-year median of 174.35. The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, CanadaBis Capital ranks better than 91.65% on this metric.
The historical rank and industry rank for CanadaBis Capital's Days Payable or its related term are showing as below:
TSXV:CANB'
s Days Payable Range Over the Past 10 Years
Min: 113.06 Med: 174.35 Max: 1036.76
Current: 335.64
During the past 10 years, CanadaBis Capital's highest Days Payable was 1036.76. The lowest was 113.06. And the median was 174.35.
TSXV:CANB's Days Payable is ranked better than 91.65% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs TSXV:CANB: 335.64
CanadaBis Capital's Days Payable
increased
from Oct. 2024 (287.74) to Oct. 2025 (384.91).
It may suggest that CanadaBis Capitaldelayed paying its suppliers.
CanadaBis Capital Days Payable Related Terms
CanadaBis Capital Days Payable Historical Data
* Premium members only.
The historical data trend for CanadaBis Capital's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:CANB vs NPHC, BSPK, CPMD: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanadaBis Capital Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Days Payable distribution charts can be found below:
* The bar in red indicates where CanadaBis Capital's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CanadaBis Capital's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CanadaBis Capital (TSXV:CANB) has a Days Payable of 384.91 as of Oct. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CanadaBis Capital and its competitors. This is 121% above median its historical median of 174.35. Over the past decade, CanadaBis Capital's Days Payable has ranged from 113.06 to 1,036.76. According to the industry distribution chart, CanadaBis Capital ranks #77 out of 922 companies in the Drug Manufacturers industry, placing it in the top 8.4%.
Is CanadaBis Capital's Days Payable too high?
CanadaBis Capital's current Days Payable of 384.91 is 121% above median its 10-year median of 174.35. Over the past 10 years, this metric has ranged from a low of 113.06 to a high of 1,036.76. The Drug Manufacturers industry median Days Payable is 90.84. CanadaBis Capital's value of 384.91 is 323.7% above this industry median. Based on the distribution chart, CanadaBis Capital ranks #77 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does CanadaBis Capital's Days Payable compare to NPHC and BSPK?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #77 out of 922 companies for Days Payable. This places CanadaBis Capital in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.84. CanadaBis Capital's value of 384.91 is 323.7% above this benchmark. Historically, CanadaBis Capital's own Days Payable has ranged from 113.06 to 1,036.76 over the past decade. While the company's 10-year median is 174.35 vs. the industry median of 90.84, CanadaBis Capital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CanadaBis Capital's current Days Payable of 384.91 is 323.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current Days Payable is 384.91, which is 121% above median its own 10-year median of 174.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current Days Payable of 384.91. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current Days Payable is 384.91, which is 121% above median its 10-year median of 174.35 and 323.7% above the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current Days Payable is 384.91 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CANB has been successfully added to your 